Fischer Medical Ventures Appoints New Independent Director, Sets AGM Date

Fischer Medical Ventures Ltd announced key board decisions following a meeting on September 3, 2026. The company approved the appointment of Mr. David Yeow as an Additional Independent Director for a term of five years, effective September 3, 2026. Following this appointment, the Audit Committee of the Board has been reconstituted. The 33rd Annual General Meeting (AGM) is scheduled for September 29, 2026, to be held via video conferencing. The register of members will be closed from September 23 to September 29, 2026, inclusive, for the AGM.